Doctor’s Lounge: Empagliflozin Ups β Cell Function in Impaired Fasting Glucose
June 20, 2017
Empagliflozin is associated with improved beta cell function in subjects with impaired fasting glucose, according to a study published online June 13 in Diabetes. Read the full story at the Doctor’s Lounge